Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by whitenorth72on Dec 13, 2023 7:04pm
116 Views
Post# 35783395

RE:RE:RE:RE:Rain cage…. A monster in the making

RE:RE:RE:RE:Rain cage…. A monster in the making

If these agreements are finalized I would assume Biggdogg is correct.
It's been pretty quiet on the home front so I'm hoping something is coming down the pipe..




Rain Cage and Voyageur are finalizing two additional agreements to define a royalty structure for Rain Cage on sales of new fullerene-based drugs and establish an equipment deployment agreement for utilizing Rain Cage carbon capture equipment and fullerene drug manufacturing equipment. In addition, Voyageur is working with Rain Cage on monetizing carbon credits, providing an additional revenue stream to strengthen the Corporation's financial position moving forward. By implementing the EDEN™ technology into our future production of imaging products, continuing to advance our social and governance goals, will allow Voyageur to meet its ESG mandates.

 

<< Previous
Bullboard Posts
Next >>